1. Home
  2. ANIP vs EYE Comparison

ANIP vs EYE Comparison

Compare ANIP & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • EYE
  • Stock Information
  • Founded
  • ANIP 2001
  • EYE 1990
  • Country
  • ANIP United States
  • EYE United States
  • Employees
  • ANIP N/A
  • EYE N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • EYE Ophthalmic Goods
  • Sector
  • ANIP Health Care
  • EYE Health Care
  • Exchange
  • ANIP Nasdaq
  • EYE Nasdaq
  • Market Cap
  • ANIP 2.0B
  • EYE 2.0B
  • IPO Year
  • ANIP N/A
  • EYE 2017
  • Fundamental
  • Price
  • ANIP $84.04
  • EYE $23.85
  • Analyst Decision
  • ANIP Strong Buy
  • EYE Buy
  • Analyst Count
  • ANIP 7
  • EYE 9
  • Target Price
  • ANIP $99.29
  • EYE $23.11
  • AVG Volume (30 Days)
  • ANIP 413.5K
  • EYE 1.9M
  • Earning Date
  • ANIP 11-07-2025
  • EYE 11-05-2025
  • Dividend Yield
  • ANIP N/A
  • EYE N/A
  • EPS Growth
  • ANIP N/A
  • EYE N/A
  • EPS
  • ANIP 1.67
  • EYE N/A
  • Revenue
  • ANIP $826,880,000.00
  • EYE $1,921,355,000.00
  • Revenue This Year
  • ANIP $40.23
  • EYE $8.59
  • Revenue Next Year
  • ANIP $9.65
  • EYE $3.59
  • P/E Ratio
  • ANIP $50.17
  • EYE N/A
  • Revenue Growth
  • ANIP 48.87
  • EYE 6.33
  • 52 Week Low
  • ANIP $52.50
  • EYE $9.93
  • 52 Week High
  • ANIP $99.50
  • EYE $29.60
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 29.50
  • EYE 39.73
  • Support Level
  • ANIP $79.39
  • EYE $23.48
  • Resistance Level
  • ANIP $95.45
  • EYE $24.91
  • Average True Range (ATR)
  • ANIP 4.46
  • EYE 1.33
  • MACD
  • ANIP -0.97
  • EYE -0.18
  • Stochastic Oscillator
  • ANIP 29.48
  • EYE 31.68

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

Share on Social Networks: